GlassScriptPhysician profile
Thomas D Gilberts
NPI 1841214236
$2,207.29
in general payments reported to CMS, 2019-2025
36 companies · $1,102 in 2025
The $1,102 reported for 2025 was more than what 86% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $676 · 2020: $191 · 2021: $15.85 · 2024: $222 · 2025: $1,102.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,325.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,324.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $261.88 | 2019-2025 | |
| Novo Nordisk INC | $227.62 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Amgen INC. | $208.33 | 2019-2025 | Evenity |
| Astrazeneca Pharmaceuticals LP | $151.91 | 2019-2025 | Airsupra |
| Glaxosmithkline, LLC. | $137.05 | 2019-2025 | Trelegy Ellipta, Arexvy |
| Sanofi-Aventis U.S. LLC | $119.28 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $79.74 | 2024-2025 | Xifaxan |
| Lilly USA, LLC | $75.02 | 2019-2025 | Kisunla |
| Boehringer Ingelheim Pharmaceuticals, INC. | $74.60 | 2019-2024 | Jardiance |
| Exact Sciences Corporation | $69.35 | 2025 | The Cologuard Plus Collection Kit |
| Madrigal Pharmaceuticals | $69.03 | 2025 | Rezdiffra |
| Vertex Pharmaceuticals Incorporated | $68.53 | 2024-2025 | |
| Philips North America LLC | $64.77 | 2019-2025 | Event, Mcot |
| Otsuka America Pharmaceutical, INC. | $54.15 | 2024-2025 | Rexulti |
| Janssen Pharmaceuticals, INC | $52.66 | 2019-2020 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $45.72 | 2019 | |
| Corcept Therapeutics | $43.00 | 2025 | Korlym |
| Horizon Therapeutics Plc | $37.10 | 2019 | |
| Abbvie INC. | $33.15 | 2025 | |
| Mylan Specialty L.P. | $31.57 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $30.49 | 2024-2025 | |
| Gilead Sciences, INC. | $26.20 | 2019-2025 | |
| Eisai INC. | $22.13 | 2025 | |
| Axsome Therapeutics, INC. | $21.65 | 2024 | Auvelity |
| Daiichi Sankyo INC. | $20.83 | 2025 | Injectafer |
| Kyowa Kirin, INC. | $20.21 | 2025 | |
| Novartis Pharmaceuticals Corporation | $20.00 | 2019 | |
| Edwards Lifesciences Corporation | $19.01 | 2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Mallinckrodt Enterprises LLC | $19.00 | 2019 | |
| Electromed, INC. | $16.85 | 2025 | Smartvest |
| Sanofi Pasteur INC. | $16.10 | 2019 | |
| Xeris Pharmaceuticals, INC. | $15.87 | 2025 | Gvoke Hypopen |
| Recordati_rare_diseases_inc. | $15.60 | 2025 | Panhematin |
| Circassia INC. | $13.87 | 2019 | |
| Boston Scientific Corporation | $12.66 | 2020 | |
| Irhythm Technologies, INC. | $12.36 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Gilberts listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.